Influenza A and Sendai Viruses Induce Differential Chemokine Gene Expression and Transcription Factor Activation in Human Macrophages  by Matikainen, Sampsa et al.
s
1
t
M
g
d
o
F
j
Virology 276, 138–147 (2000)
doi:10.1006/viro.2000.0542, available online at http://www.idealibrary.com onInfluenza A and Sendai Viruses Induce Differential Chemokine Gene Expression and
Transcription Factor Activation in Human Macrophages
Sampsa Matikainen, Jaana Pirhonen, Minja Miettinen, Anne Lehtonen, Carola Govenius-Vintola,
Timo Sareneva, and Ilkka Julkunen1
Department of Virology, National Public Health Institute, FIN-00300 Helsinki, Finland
Received April 14, 2000; returned to author for revision June 5, 2000; accepted July 12, 2000
Chemokines regulate leukocyte traffic and extravasation into the site of inflammation. Here we show that influenza A- or
Sendai virus-infected human macrophages produce MIP-1a, MIP-1b, RANTES, MCP-1, MCP-3, MIP-3a, IP-10, and IL-8,
whereas no upregulation of MIP-3b, eotaxin, or MDC production was detected. Influenza A virus was a better inducer of
MCP-1 and MCP-3 production than Sendai virus, whereas MIP-1a, MIP-1b, RANTES, MIP-3a, and IL-8 were induced
preferentially by Sendai virus. Infection in the presence of protein synthesis inhibitor indicated that ongoing protein synthesis
was required for influenza A virus-induced expression of MCP-1, MCP-3, and IP-10 genes, whereas Sendai virus-induced
chemokine mRNA expression took place in the absence of de novo protein synthesis. Neutralization of virus-induced IFN-a/b
resulted in downregulation of virus-induced IP-10, MCP-1, and MCP-3 mRNA expression. IFN-a or IFN-g were found to
directly enhance MCP-1, MCP-3, and IP-10 mRNA expression. Both influenza A and Sendai viruses similarly activated
transcription factor NF-kB. In contrast to NF-kB, IRFs and STATs, the other transcription factors involved in the regulation of
chemokine gene expression, were differentially activated by these viruses. Influenza A virus more efficiently activated ISGF3
complex formation and Stat1 DNA-binding compared to Sendai virus, which in turn was a more potent activator of IRF-1. Our
results show that during viral infections macrophages predominantly produce monocyte and Th1 cell attracting chemokines.
Furthermore, virus-induced IFN-a/b enhanced chemokine gene expression in macrophages emphasizing the role of IFN-a/b
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INTRODUCTION
Influenza A and Sendai (murine parainfluenza type 1)
viruses infect primarily upper respiratory tract epithelial
cells. In addition, they infect T cells and monocytes/
macrophages (Cantell et al., 1981; Ronni et al., 1995,
1997; Bussfeld et al., 1997, 1998; Sareneva et al., 1998;
Pirhonen et al., 1999). Macrophages are involved in ini-
tiating innate and adaptive immune responses against
viruses and other intracellular pathogens (Unanue, 1993).
During viral infections macrophages produce a number
of different cytokines and chemokines. Influenza A virus-
infected monocytes/macrophages produce, e.g., IL-1b,
IL-6, TNF-a, IFN-a/b, and IL-18 (Gong et al., 1991; Pe-
chke et al., 1993; Hofmann et al., 1997; Sareneva et al.,
998; Pirhonen et al., 1999), which are important activa-
ors of T cells, macrophages, and dendritic cells (Van der
eer et al., 1998; Dinarello, 1999). Recent evidence sug-
ests that IFN-a/b, which is essential for antiviral immu-
nity (Vilcek and Sen, 1996; Zinkernagel and Hengartner,
1997), also modulates cell-mediated immune responses.
For instance, IFN-a/b enhances survival of activated T
1 To whom correspondence and reprint requests should be ad-
ressed at Laboratory of Viral and Molecular Immunology, Department
f Virology, National Public Health Institute, Mannerheimintie 166,
IN-00300 Helsinki, Finland. Fax: 1358-9-47448355. E-mail: ilkka.
ulkunen@ktl.fi.
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138ess
ells (Marrack et al., 1999; Matikainen et al., 1999), up-
egulates IFN-g gene expression in T cells, and favors
he development of the Th1 immune response (Rogge et
l., 1997; Sareneva et al., 1998).
Chemokines play an important role in immune and
inflammatory reactions, as well as in viral infections.
They regulate the recruitment and functional activation of
leukocytes (Baggiolini, 1998; Luster, 1998). Some chemo-
kines, e.g., MDC2 and SDF-1, are produced constitutively
y specialized cells and organs while the production of
ost chemokines requires specific activation signals.
onocytes/macrophages have been shown to respond
o virus infection by producing chemokines (Sprenger et
l., 1996; Hofmann et al., 1997; Bussfeld et al., 1998).
ifferential expression of chemokine receptors in differ-
nt leukocyte populations regulates their responsive-
ess to chemokines (Baggiolini, 1998; Luster, 1998; Sal-
usto et al., 1998a). Monocytes and immature dendritic
ells express CCR1, CCR2, and CCR5 and are thus re-
ponsive for MIP-1a/b, RANTES, and various MCPs. Eo-
sinophils, basophils, and Th2 cells respond to these
2 Abbreviations used: CCR, CC chemokine receptor; CXCR, CXC
hemokine receptor; IRF, IFN regulatory factor; ISGF3, IFN-stimulated
ene factor 3; IP-10, inflammatory protein-10; MCP, monocyte chemoat-
ractant protein; MDC, macrophage-derived chemokine; MIP, macro-
hage inflammatory protein; RANTES, regulated upon activation, nor-
al T cell expressed and secreted; RSV, respiratory syncytial virus;
DF, stroma-derived factor.
B
v
P
C
a
i
p
a
d
M
v
1
M
(
p
IN VIchemokines as well, but in addition, they contain eotaxin
receptor, CCR3 (Sallusto et al., 1997). Th1 cells are re-
sponsive to IP-10, since they selectively express CXCR3
(Bonecchi et al., 1998; Sallusto et al., 1998b).
The transcriptional systems activated during Influenza
A and Sendai virus infections include IRFs, NF-kB, and
STATs. IRF-3 is activated by Sendai virus leading to the
induction of RANTES gene expression (Lin et al., 1999).
oth Influenza A and Sendai viruses are known to acti-
ate transcription factor NF-kB (Garoufalis et al., 1994;
ahl and Bauerle, 1995; Ronni et al., 1997). NF-kB en-
hances the expression of many cytokine and chemokine
genes including IL-8, IP-10, MCP-1, and RANTES (Choi
and Jacoby, 1992; Garofalo et al., 1996; Ueda et al., 1997;
heng et al., 1998; Thomas et al., 1998). Viral infections
pparently do not activate STATs directly, rather virus-
nduced cytokines, especially IFN-a, can activate multi-
le STAT proteins. STATs are involved at least in the
ctivation of IP-10 and MCP-1 gene expression (Majum-
er et al., 1998; Valente et al., 1998; Ito et al., 1999).
In the present study we have analyzed chemokine
production and activation of transcription factors that are
involved in the induction of chemokine gene expression
in macrophages infected with influenza A or Sendai
viruses. The chemokines analyzed are representative
members of the chemokine families corresponding to the
ligands for CCR1–CCR7 and CXCR1–CXCR3 chemokine
receptors. We show that influenza A and Sendai viruses
induce differential chemokine production and activation
of transcription factors involved in the regulation of che-
mokine genes.
RESULTS
Kinetics of chemokine mRNA synthesis in macrophages
infected with influenza A or Sendai viruses
To study virus-induced chemokine gene expression
we infected macrophages with influenza A or Sendai
viruses. At different time periods after infection cells and
cell culture supernatants were collected, total cellular
RNA was isolated, and chemokine mRNA expression
was analyzed by Northern blotting. MIP-1a, MIP-1b,
CP-1, MCP-3, and IP-10 mRNAs were induced by both
iruses and peak mRNA levels were detected at 6 and
2 h after infection (Fig. 1). In contrast, virus-induced
IP-3a mRNA levels peaked at 3 and 6 h after infection
Fig. 1). MIP-1a, MIP-1b, RANTES, and MIP-3a mRNA
levels in macrophages infected with Sendai virus were
higher compared to that of influenza A virus-infected
cells. MIP-3b (ELC), the ligand for CCR7 (Baggiolini,
1998; Luster, 1998; Sallusto et al., 1998a), was not ex-
pressed in uninfected or virus-infected macrophages
(data not shown). Both viruses clearly induced IP-10,
MCP-1, and MCP-3 mRNA expression (Fig. 1), whereas
IL-8 gene expression was upregulated only by Sendai
CHEMOKINE GENE EXPRESSIONvirus. MDC mRNA was constitutively expressed in mac-
rophages, although some reduction in MDC mRNA lev-
l
Cels was seen in influenza A virus-infected cells. This may
result from the ability of influenza A virus polymerase
protein complex to destroy host cell pre-mRNAs (Lamb
and Krug, 1996).
Chemokine secretion from virus-infected
macrophages
As shown in Fig. 1, the expression of several chemo-
kine genes was turned on in virus-infected macro-
phages. To study whether virus infection leads to en-
hanced chemokine protein production, we measured
chemokine levels in cell culture supernatants by ELISA.
MIP-1a, RANTES, IP-10, and IL-8 were detected in su-
ernatants collected at 3 h after infection and the peak
FIG. 1. Northern blot analysis of chemokine mRNA synthesis in
influenza A- and Sendai virus-infected macrophages. Primary human
macrophages from four individual blood donors were infected with
influenza A or Sendai viruses for 3, 6, 12, and 24 h. Cells were collected
and pooled, and total cellular RNA was isolated. Equal amounts (20 mg)
of RNA were size-fractionated by formaldehyde–agarose gel electro-
phoresis and subjected to Northern blot analysis. To control equal RNA
loading, ethidium bromide staining of ribosomal RNA bands was used.
139RUS-INFECTED MACROPHAGESevels were found at 12 and 24 h after infection (Fig. 2).
onsistent with the Northern blot data, both viruses in-
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lthough differences in expression levels were found.
nfluenza A virus infection enhanced the production of
CP-1 and MCP-3, whereas Sendai virus infection
oorly induced these chemokines (Fig. 2). However, in
endai virus-infected cells enhanced levels of MCP-1
nd MCP-3 mRNAs were found (Fig. 1). This may suggest
hat additional stimuli provided by influenza A, but not by
endai virus infection, are required for efficient transla-
ion of MCP mRNAs and production of the respective
roteins (Fig. 2). Eotaxin production was not detected in
irus-infected macrophages (data not shown).
he effect of protein synthesis inhibition
n chemokine gene expression
To further analyze the molecular mechanisms of virus-
nduced chemokine gene expression, we infected mac-
ophages in the presence of cycloheximide. In cyclohex-
mide-treated control cells elevated MIP-1a, MIP-1b,
MIP-3a, and IL-8 mRNA levels were detected (Fig. 3). In
FIG. 2. Kinetics of chemokine production by virus-infected macrop
supernatants were collected at different time points after infection a
individual experiments.
140 MATIKAendai virus-infected macrophages mRNA expression of
IP-1a, MIP-1b, RANTES, MIP-3a, and IL-8 genes was
o
npregulated in the presence of cycloheximide. In con-
rast, cycloheximide treatment resulted in a significant
eduction in Sendai virus-induced MCP-1 mRNA levels
nd in some reduction in Sendai virus-induced MCP-3
RNA expression. In influenza A virus-infected cells cy-
loheximide reduced or almost completely blocked
CP-1, MCP-3, and IP-10 mRNA expression, suggesting
hat ongoing protein synthesis was required for virus-
nduced activation of these genes (Fig. 3).
he role of IFN-a/b in virus-induced chemokine gene
expression
IFN-a/b is essential for host antiviral responses (Vil-
cek and Sen, 1996; Zinkernagel and Hengartner, 1997)
and its production is induced in leukocytes and macro-
phages by influenza A and Sendai viruses (Cantell et al.,
1981; Ronni et al., 1995; Cantell and Pirhonen, 1996; Hua
et al., 1996; Sareneva et al., 1998; Pirhonen et al., 1999).
Therefore, we analyzed whether IFN-a/b had a role in
irus-induced chemokine gene expression. Influenza A-
Macrophages were infected with influenza A or Sendai viruses and
lyzed with ELISAs. The results represent the means (6SD) of three
ET AL.hages.
INENr Sendai virus-infected macrophages were treated with
eutralizing anti-IFN-a/b Abs and chemokine gene ex-
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IN VIpression was analyzed by Northern blotting at 4 and 6 h
after infection. Treatment of virus-infected macrophages
with anti-IFN-a/b Abs had no effect on MIP-1a, MIP-1b,
or RANTES mRNA synthesis (Fig. 4), suggesting that
IFN-a/b does not have a major role in the regulation of
these genes. MCP-1 and MCP-3 mRNA levels were
readily induced by both viruses and anti-IFN-a/b Abs
nhibited their expression to some extent. Influenza A
irus-induced expression of IP-10 mRNA was almost
ompletely inhibited by anti-IFN-a/b Abs, suggesting that
IFN-a/b may be a primary regulator of IP-10 gene ex-
FIG. 3. Induction of virus-induced chemokine gene expression in the
presence of protein synthesis inhibitor. Macrophages were treated with
protein synthesis inhibitor cycloheximide (10 mg/ml) for 30 min followed
by infection with influenza A or Sendai viruses. Cells were collected at
4 and 6 h after infection and pooled and total cellular RNA was isolated.
Twenty micrograms of total cellular RNA was size-fractionated by
electrophoresis and analyzed by Northern blotting.
CHEMOKINE GENE EXPRESSIONression. Anti-IFN-a/b Abs had only marginal effect on
Sendai virus-induced IP-10 gene expression suggestingthat both IFN-dependent and IFN-independent activation
pathways exist.
IFNs upregulate MCP-1, MCP-3, and IP-10 gene
expression
To further study the role of IFNs in the regulation
MCP-1, MCP-3, and IP-10 gene expression we stimulated
macrophages with IFN-a or IFN-g. As shown in Fig. 5,
oth IFN-a and IFN-g upregulated MCP-1, MCP-3, and
P-10 mRNA synthesis. Already at 1 h after IFN treatment,
nhancement of MCP-1, MCP-3, and IP-10 mRNA expres-
ion was detected. Results from Northern blot analyses
upport the idea that IFNs may regulate the expression
f MCPs and IP-10. In macrophages IFN-a and IFN-g
enhanced IP-10 gene expression equally well. MIP-1a
and MIP-3a genes were not induced by IFN-a or IFN-g,
hereas RANTES mRNA expression was weakly in-
uced by IFN-a (data not shown).
FIG. 4. The effect of neutralizing anti-IFN-a/b Abs on virus-induced
chemokine gene expression. Macrophages were infected with influ-
enza A or Sendai viruses and 1 h after infection anti-IFN-a (2300
neutralizing U/ml) and anti-IFN-b (170 neutralizing U/ml) Abs were
141RUS-INFECTED MACROPHAGESadded. The cells were collected at 4 or 6 h after infection and pooled
and total cellular RNA was isolated followed by Northern blot analysis.
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1 INENVirus- and IFN-induced Stat1 DNA-binding
to the MCP-1 GAS
Previous analyses have shown that STATs are involved
in the activation of MCP-1 gene expression (Valente et
al., 1998). To study the mechanisms of virus- and IFN-
induced MCP-1 gene expression in human macro-
phages, we performed electrophoretic mobility shift as-
say (EMSA) with MCP-1 GAS probe. Both influenza A
and Sendai viruses induced detectable DNA-binding
complexes to MCP-1 GAS at 3 h after infection (Fig.
6A). However, Sendai virus-induced protein/DNA com-
plex was very weak compared to that induced by influ-
enza A virus. The virus-induced complex consisted of
Stat1 proteins since only anti-Stat1 Abs supershifted the
complex (Fig. 6A). Stimulation of macrophages with
IFN-a or IFN-g resulted in a clearly detectable MCP-1
GAS binding complex (Fig. 6B). IFN-a-induced DNA-bind-
ng complex disappeared at 3 h after stimulation,
hereas IFN-g-induced protein/DNA complex persisted
at least for 9 h after stimulation. As in the case of virus
infection, supershift analyses suggested that IFN-in-
FIG. 5. Induction of MCP-1, MCP-3, and IP-10 mRNA synthesis in
IFN-a or IFN-g stimulated macrophages. Macrophages were stimu-
lated with (A) IFN-a (1000 IU/ml) or (B) IFN-g (100 IU/ml) and cells from
our individual blood donors were collected at different times after
timulation. Total cellular RNA (20 mg) was size-fractionated on aga-
ose gels, transferred to nylon membranes, and hybridized with MCP-1,
CP-3, and IP-10 probes.
42 MATIKAduced DNA-binding complexes consisted mainly of Stat1
protein (Fig. 6B).
i
1Influenza A and Sendai virus infection differentially
induce ISGF3 complex formation and
IRF-1 DNA-binding in macrophages
In addition to STATs, IRFs and NF-kB-transcription fac-
tors regulate chemokine gene expression. To study vi-
rus-induced activation of IRF and NF-kB we performed
EMSA with ISRE15 and RANTES NF-kB oligonucleotides.
ISGF3, a heterotrimer of Stat1, Stat2, and p48 proteins,
binds to ISRE15 in response to IFN-a/b stimulation. The
RF-1 DNA-binding site overlaps with that of ISGF3 and
RF-1 DNA-binding to ISRE15 is induced by IFNs (Ma-
ane et al., 1999). Both influenza A and Sendai viruses
nduced IRF-1 and ISGF3 DNA-binding at 3 h after infec-
ion (Fig. 7A). However, influenza A virus more efficiently
nduced ISGF3 complex formation compared to Sendai
irus, whereas Sendai virus was a much more potent
nducer of IRF-1 DNA-binding (Fig. 7A). The identity of the
SGF3 complex was verified with supershift experiments
ith anti-Stat1, anti-Stat2, and anti-p48 Abs (data not
hown). The IRF-1 DNA-binding complex was most likely
RF-1 homodimer, since it was supershifted with anti-
RF-1 Abs but not with anti-ICSBP, anti-IRF-2, or anti-p48
bs (data not shown). In Sendai virus-infected macro-
hages, we detected a slower migration DNA-binding
omplex (Fig. 7A), which did not react with anti-IRF-1,
nti-IRF-2, anti-p48, anti-Stat1, anti-Stat3, or anti-Stat5
bs (data not shown).
Both Influenza A and Sendai viruses induced DNA-
inding activity to the RANTES NF-kB site already at 1 h
after infection (Fig. 7B). Thereafter, NF-kB DNA-binding
eclined and was strongly reinduced at 6–9 h after the
nfection. Similar results were obtained with consensus
F-kB oligonucleotide (data not shown).
DISCUSSION
In this study we analyzed chemokine gene expression
in influenza A- and Sendai virus-infected human macro-
phages. Macrophages are found in most tissues where
they produce cytokines, phagocytose cell debris and
microbes, and present antigens (Unanue, 1993). Virus-
infected macrophages produce proinflammatory cyto-
kines, IL-1, IL-6, and TNF-a (Gong et al., 1991; Peschke et
l., 1993; Hofmann et al., 1997; Sareneva et al., 1998;
Pirhonen et al., 1999), as well as IFN-a/b and IL-18,
which favor the development Th1 immune responses
(Rogge et al., 1997; Sareneva et al., 1998; Dinarello, 1999).
Influenza A and Sendai viruses have been used in
tudies concerning virus–host cell interactions and cyto-
ine gene expression (Gong et al., 1991; Peschke et al.,
993; Ronni et al., 1995, 1997; Hofmann et al., 1997; Lin et
l., 1998; Sareneva et al., 1998; Pirhonen et al., 1999). One
f the advantages of these viruses is that a syncronous
nfection can be established in many cell types. In mac-
ophages viral protein synthesis starts within 4–6 h after
ET AL.nfluenza A and Sendai virus infection (Sareneva et al.,
998; Pirhonen et al., 1999). Enhanced expression of
h
i
t
c
N
1
t
w
o
a
f
e
m
c
i
S
S
I
w
p
S
e
l
i
c
v
uclearMIP-1a, RANTES, and IL-8 was seen during the first
ours of infection (Figs. 1 and 2). This suggests that
nfluenza A and Sendai viruses can rapidly activate the
ranscriptional systems involved in the upregulation of
hemokine gene expression. These systems include
F-kB (Baldwin, 1996) and IRFs (Mamane et al., 1999),
which are activated by influenza A virus (Pahl and
Bauerle, 1995; Ronni et al., 1997) and by certain members
of the paramyxoviridae (Lin et al., 1998, 1999; Marie´ et al.,
998; Yoneyama et al., 1998). NF-kB enhances IL-8 gene
ranscription (Kunsch et al., 1994; Garofalo et al., 1996)
hile both IRFs and NF-kB regulate RANTES gene ex-
pression (Matsukura et al., 1998; Thomas et al., 1998; Lin
et al., 1999). IP-10 and MCP-1 gene expression is in-
duced by IFNs (Luster et al., 1985; Satriano et al., 1993)
and STATs are involved in the activation of these genes
(Tebo et al., 1998; Valente et al., 1998; Ito et al., 1999). In
ur experiments influenza A and Sendai viruses similarly
ctivated NF-kB DNA-binding. However, ISGF3 complex
ormation and IRF-1 and Stat1 DNA-binding were differ-
ntially activated by influenza A and Sendai viruses. This
ay, at least in part, explain the differential induction of
hemokine gene expression. Compared to Sendai virus,
FIG. 6. Virus- and IFN-induced STAT binding to MCP-1 GAS. Macrop
with IFN-a (100 IU/ml) or IFN-g (100 IU/ml) for the indicated times, and
MCP-1 GAS probe and analyzed by EMSA. In supershift experiments n
EMSA with MCP-1 GAS.
CHEMOKINE GENE EXPRESSIONnfluenza A virus was a much better inducer of ISGF3 and
tat1 DNA-binding although macrophages infected withendai virus produce 10- to 100-fold higher levels of
FN-a/b (Pirhonen et al., 1999). In contrast, Sendai virus
as a more potent inducer of IRF-1 DNA-binding com-
ared to influenza A virus. Recently, it was shown that
endai virus C protein interferes with IFN-induced Stat1
xpression (Garcin et al., 1999) which may explain, at
east in part, poor STAT activation during Sendai virus
nfection.
Influenza A and Sendai viruses differentially activated
hemokine gene expression in macrophages. Sendai
irus was a potent inducer of MIP-1a, MIP-1b, and
RANTES genes, which was seen both at mRNA and at
protein expression levels. Up to 100–300 ng/ml of MIP-1a
and RANTES was found in cell culture supernatants of
Sendai virus-infected macrophages. These values were
approximately 10-fold higher compared to those induced
by influenza A virus. IL-8 production was induced pref-
erentially by Sendai virus. The lack of IL-8 production by
influenza A virus is consistent with previous observa-
tions in monocytes (Sprenger et al., 1996; Bussfeld et al.,
1998). This suggests that in macrophages Sendai virus
induces chemokines that attract cells expressing CCR1,
CCR3, and CCR5 (receptors for MIP-1a, MIP-1b, and
were (A) infected with influenza A or Sendai viruses or (B) stimulated
extracts were prepared. The extracts were incubated with 32P-labeled
extracts were incubated for 1 h on ice with anti-STAT Abs, followed by
143RUS-INFECTED MACROPHAGEShages
nuclear
IN VIRANTES) and CXCR1 and CXCR2 (receptors for IL-8).
Sendai virus-induced chemokines could favor the recruit-
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INENment of a broad spectrum of inflammatory cells, since
the receptors mentioned above are found in monocytes,
immature dendritic cells, and all species of granulocytes
(Baggiolini, 1998; Luster, 1998; Sallusto et al., 1998a).
reviously, influenza A virus and RSV have been shown
o induce IL-8 and RANTES expression in airway epithe-
ial cells (Choi and Jacoby, 1992; Garofalo et al., 1996;
Mastronarde et al., 1996; Saito et al., 1997; Matsukura et
al., 1998; Olszewska-Pazdrak et al., 1998).
Another difference between influenza A and Sendai
viruses was found in MCP-1 and MCP-3 production.
Although both viruses rapidly (at 3 h) induced the mRNA
expression of these genes (Fig. 1), only macrophages
infected with influenza A virus efficiently secreted MCP-1
and MCP-3. Induction of MCP-1 and MCP-3 mRNA was
stronger in influenza A virus-infected cells, but it is un-
likely that the difference in the mRNA expression levels
alone could explain the differences in MCP protein pro-
duction. It is possible that MCP-1 and MCP-3 synthesis is
translationally or posttranslationally regulated during vi-
ral infections and only influenza A virus can efficiently
enhance protein production/secretion. Enhanced secre-
tion of MCP-1 and MCP-3 in influenza A virus infection
and complete lack of eotaxin production could favor the
selective recruitment of the blood mononuclear cell pop-
ulation to the site of influenza A virus infection.
FIG. 7. (A) Influenza A- and Sendai virus-induced IRF-1 and ISGF3
DNA-binding to ISRE15. Macrophages were infected with influenza A or
Sendai viruses or stimulated with IFN-a (100 IU/ml) for the indicated
times. After that nuclear extracts were prepared and analyzed by EMSA
with ISRE15 probe. (B) Influenza A- and Sendai virus-induced NF-kB
inding to RANTES NF-kB site. Macrophages were infected with influ-
enza A or Sendai viruses for the indicated times. Nuclear extracts were
prepared and analyzed by EMSA with RANTES NF-kB probe.
144 MATIKAWe observed that the expression of MIP-3a (LARC),
ut not MIP-3b (ELC), was induced by influenza A andSendai viruses. CCR6, the receptor for MIP-3a, is found
in immature dendritic cells (DC) (Sallusto et al., 1998b)
and therefore virus-induced MIP-3a production could be
involved in the recruitment of immature DCs to the site of
infection. The lack of MIP-3b production in virus-infected
macrophages is noteworthy. MIP-3b production may be
estricted to activated DCs (Sallusto et al., 1999), which
ecome CCR7 positive and by autocrine stimulatory
echanisms (via MIP-3b production) then migrate to
local lymph nodes. This suggests that during viral infec-
tions macrophages and DCs have clearly different roles.
Macrophages are involved, via MIP-3a production (Fig.
1), in recruitment of monocytes and immature DCs into
the site of inflammation. Activated DCs in tissues are,
after antigen sampling and via MIP-3b production
(Sallusto et al., 1999), involved in initiating their own
migration from the site of inflammation to local lymph
nodes (Cyster, 1999; Sallusto et al., 1998b; Sozzani et al.,
1998).
IP-10, initially described as an IFN-g-inducible inflam-
atory protein (Luster et al., 1985), was readily secreted
by influenza A- and Sendai virus-infected macrophages.
Since IP-10 is regulated by IFN-g and its promoter has
IFN-responsive elements (Tebo et al., 1998; Ito et al.,
1999) we reasoned that this gene could also be regu-
lated by IFN-a/b during viral infections. Neutralization
experiments with anti-IFN-a/b Abs clearly showed that
influenza A virus-induced IP-10 gene expression is de-
pendent on virus-induced IFN-a/b production. In the
ase of Sendai virus IFN-independent transcriptional ac-
ivation of IP-10 gene was seen. As most viral infections
ead to the production of IFN-a/b and subsequently IP-
0, this phenomenon has relevance in the biology of viral
nfection. IP-10 specifically attracts Th1 cells, due to their
xpression of CXCR3 (Bonecchi et al., 1998; Sallusto et
l., 1998b; Siveke and Hamann, 1998), leading to the
ecruitment of Th1 cells into the site of inflammation.
ecent evidence suggests that IFN-a/b is an important
ytokine in Th1 immune response, since it favors, to-
ether with macrophage-produced IL-12 and IL-18 (Ma-
ram et al., 1996; Takeda et al., 1998), Th1 cell develop-
ment (Rogge et al., 1997). IFN-a/b also enhances T cell
survival (Marrack et al., 1999; Matikainen et al., 1999) and
irectly upregulates IFN-g production in T cells (Sar-
neva et al., 1998). In addition, IFN-a has been shown to
upregulate CCR1 and downregulate CCR3 expression,
further favoring the Th1-type immune response (Sallusto
et al., 1997). These observations emphasize the impor-
tant role of IFN-a/b both in the development of cell-
mediated immunity and as substances involved in mono-
nuclear cell chemoattraction during viral infections.
MATERIALS AND METHODS
Isolation and culture of macrophages
ET AL.PBMCs were isolated by Ficoll–Paque (Pharmacia Bio-
technology, Uppsala, Sweden) density gradient centrifu-
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IN VIgation from leukocyte-rich buffy coats of healthy human
blood donors (Finnish Red Cross Blood Transfusion Ser-
vice, Helsinki, Finland). Cells were allowed to bind onto
six-well plastic plates (Falcon Multiwell, Becton–Dickin-
son, Franklin Lakes, NJ) for 1 h at 37°C in 5% CO2. After
incubation, nonadherent cells were removed and adher-
ent cells (monocytes) were washed twice with PBS, pH
7.4. Monocytes were differentiated into macrophages in
the presence of GM-CSF (10 ng/ml) (Leucomax; Scher-
ing-Plough, Innishannon, Ireland) as previously de-
scribed (Pirhonen et al., 1999).
RNA isolation and analysis
Total cellular RNA was prepared using the guani-
dinium isothiocyanate/cesium chloride method (Glisin et
al., 1974; Chirgwin et al., 1979). The amount of total
ellular RNA was quantified photometrically. Equal
mounts (20 mg) of total cellular RNA were size-fraction-
ated on a 1% formaldehyde–agarose gel, transferred to a
nylon membrane (Hybond, Amersham, Buckinghamshire,
UK), and analyzed by Northern blotting. cDNA probes
were labeled with [a-32P]dCTP (3000 Ci/mol; Amersham,
uckinghamshire, UK) using a random primed DNA la-
eling kit (Boehringer Mannheim Corp., Indianapolis, IN).
ybridizations were done in a solution containing 50%
ormamide, 53 Denhardt’s solution, 53 standard saline–
hosphate–EDTA, and 0.5% SDS at 42°C. Membranes
ere washed twice with 13 SSC/0.1% SDS for 30 min at
2°C and once for 30 min at 60°C. cDNAs coding for
uman MIP-1a, MIP-1b, RANTES, MCP-1, MCP-3, and
DC genes were provided by Dr. Mantovani (Instituto di
icerche Farmacologiche, Milan, Italy). IL-8, MIP-3a, and
MIP-3b (Rossi et al., 1997) cDNAs were from DNAX
esearch Institute (Palo Alto, CA). IP-10 cDNA was
loned from total RNA obtained from IFN-g-induced
macrophages by RT-PCR using oligonucleotides TCCAG-
TGGATCCACCATGAATCAAACTGCGATTCTGATT (sense)
and TGCTCCGGATCCGTTTTAAGGAGATCTTTTAGACA-
TTTCCTT (antisense). Equal RNA loading in Northern
blots was controlled by ethidium bromide staining of
ribosomal RNA bands or by hybridization with glycer-
aldehyde phosphate dehydrogenase or b-actin cDNA
probes.
Viruses and infection
The stock of human pathogenic influenza virus (A/
Beijing/353/89 H3N2) is from the National Institute of
Medical Research (London, UK) and the murine Sendai
virus stock (strain Cantell) is from our Institute. Both virus
stocks were cultured in 8-day-old embryonated hen’s
eggs and stored at 270°C (Cantell et al., 1981; Ronni et
al., 1995). The hemagglutination titers of influenza A and
Sendai viruses were 128 and 6000, respectively. Macro-
phages were infected with influenza A (5 pfu/cell) or
CHEMOKINE GENE EXPRESSIONSendai viruses (10 pfu/cell) in 2 ml of Macrophage-SFM
medium. Flow cytometric analysis has confirmed that95–99% of the cells were infected with the virus doses
used in the experiments (Pirhonen et al., 1999). After 1 h,
the virus was removed, plates were washed with PBS,
and the cells were cultured in RPMI 1640 supplemented
with 10% FCS and antibiotics. The cells and supernatants
were collected at different time points after infection as
indicated in each experiment. Macrophages from indi-
vidual donors were grown and infected separately, and
the samples of four individual donors were pooled in
each experiment.
Chemokine ELISAs and assay for IFN-a/b
MIP-1a, RANTES, MCP-1, MCP-3, IP-10, eotaxin, and
L-8 concentrations in supernatants were measured us-
ng ELISA with Ab pairs and standards obtained from
&D Systems (Abingdon, UK). IFN-a/b levels were de-
ermined by a biological assay using a vesicular stoma-
itis virus plaque reduction assay in Hep2 cells (Cantell
t al., 1991).
FNs and anti-IFN-a/b antibodies
Human leukocyte IFN-a was prepared and purified as
previously described (Cantell et al., 1981). Human IFN-g
was obtained from the Finnish Red Cross Blood Trans-
fusion Service (Cantell et al., 1986). For neutralizing IFN-
a/b activity 2300 neutralizing U/ml for IFN-a and 170
neutralizing U/ml for IFN-b were used (Mogensen et al.,
1975).
Cycloheximide treatment
Cycloheximide (10 mg/ml; Sigma, St. Louis, MO) was
used to block protein synthesis during virus infection and
it was present throughout the experiment. The concen-
tration of cycloheximide used is sufficient to totally block
protein synthesis in human blood mononuclear cells
(Ronni et al., 1995).
Electrophoretic mobility shift assay
Nuclear extracts and nuclear protein/DNA-binding re-
actions were performed as described previously (An-
drews and Faller, 1991; Matikainen et al., 1996). MCP-1
AS: (59-GATCGCTTCCCTTTCCTACTTCCTGGAAATCCA-
9), RANTES NF-kB: (59-GATCTTGGAAACTCCCCT-
TAGGGGATGCCCCTCAA), and ISRE15 (59-GATCAGCTT-
GATCGGGAAAGGGAAACCGAAACTGAAGCCA-39) oligo-
nucleotides were synthesized with an Applied
Biosystems (Foster City, CA) oligonucleotide synthesizer
and purified on PAGE in the presence of 8 M urea. The
probes were labeled by Klenow-fill in reaction. The bind-
ing reaction was performed at room temperature for 30
min. The samples were analyzed by electrophoresis on
6% nondenaturing low-ionic-strength polyacrylamide
gels in 0.253 TBE. The gels were dried and visualized by
145RUS-INFECTED MACROPHAGESautoradiography. Anti-Stat1 (sc-345X, Santa Cruz Bio-
technology, Santa Cruz, CA), anti-Stat3 (sc-482X, Santa
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1 INENCruz), and anti-Stat5 (sc-835X, Santa Cruz) Abs (1:20
dilution) were used in supershift experiments.
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